Imaging of testicular germ cell tumours

Cancer Imaging

Volumn 6, Issue 1, 2006, Pages 124-134

  Dalal, P U ^a   Sohaib, S A ^a   Huddart, R ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

CT; Germ cell neoplasia; Imaging; MRI; PET; Testicular tumours

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; MALE; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; TESTIS TUMOR;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; POSITRON-EMISSION TOMOGRAPHY; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748866472     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2006.0020     Document Type: Article

References (85)

1. Coakley FV, Hricak H, Presti JC Jr. Imaging and management of atypical testicular masses. Urol Clin North Am 1998; 25: 375-88.
2. Guthrie JA, Fowler RC. Ultrasound diagnosis of testicular tumours presenting as epididymal disease. Clin Radiol 1992; 46: 397-400.
3. Richie JP, Steele GS. Neoplasms of the testis. In: Campbell's Urology, 8th edn. Walsh PC, Retik AB, Vaughan ED, eds. Philadelphia., PA: Saunders, 2001: 2876-919.
4. Grantham JG, Charboneau JW, James EM, Kirschling RJ, Kvols LK, Segura JW et al. Testicular neoplasms: 29 tumors studied by high-resolution US. Radiology 1985; 157: 775-80.
5. Senay BA, Stein BS. Testicular neoplasm diagnosed by ultrasound. J Surg Oncol 1986; 32: 110-12.
6. Rifkin MD, Kurtz AB, Pasto ME, Goldberg BB. Diagnostic capabilities of high-resolution scrotal ultrasonography: prospective evaluation. J Ultrasound Med 1985; 4: 13-19.
7. Horstman WG, Melson GL, Middleton WD, Andriole GL. Testicular tumors: findings with color Doppler US. Radiology 1992; 185: 733-7.
8. Johnson JO, Mattrey RF, Phillipson J. Differentiation of seminomatous from nonseminomatous testicular tumors with MR imaging. AJR Am J Roentgenol 1990; 154: 539-43.
9. Thurnher S, Hricak H, Carroll PR, Pobiel RS, Filly RA. Imaging the testis: comparison between MR imaging and US. Radiology 1988; 167: 631-6.
10. Sobin LH, Wittekind CH. UICC: TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002.
11. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603.
12. Dixon AK, Ellis M, Sikora K. Computed tomography of testicular tumours: distribution of abdominal lymphadenopathy. Clin Radiol 1986; 37: 519-23.
13. Mason MD, Featherstone T, Olliff J, Horwich A. Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy. Clin Oncol (R Coll Radiol) 1991; 3: 147-50.
14. Williams MP, Cook JV, Duchesne GM. Psoas nodes: an overlooked site of metastasis from testicular tumours. Clin Radiol 1989; 40: 607-9.
15. Rouviere H. Anatomy of the Human Lymphatic System. Ann Arbor, MI: Edwards Brothers, 1938.
16. Macdonald JS, Paxton RM. Lymphography. In: Scientific Foundations of Urology, Chisholm GD, ed. Oxford: Heinemann Medical, 1976.
17. Wood A, Robson N, Tung K, Mead G. Patterns of supradiaphragmatic metastases in testicular germ cell tumours. Clin Radiol 1996; 51: 273-6.
18. Fernandez EB, Moul JW, Foley JP, Colon E, McLeod DG. Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors. Urology 1994; 44: 548-52.
19. Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-99.
20. White PM, Adamson DJ, Howard GC, Wright AR. Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol 1999; 54: 207-11.
21. Richie JP. Detection and treatment of testicular cancer. CA Cancer J Clin 1993; 43: 151-75.
22. Husband JE, Grimer DP. Staging testicular tumours: the role of CT scanning. J R Soc Med 1985; 78 (Suppl 6): 25-31.
23. Muhm JR, Brown LR, Crowe JK. Detection of pulmonary nodules by computed tomography. AJR Am J Roentgenol 1977; 128: 267-70.
24. Williams MP, Husband JE, Heron CW. Intrathoracic manifestations of metastatic testicular seminoma: a comparison of chest radiographic and CT findings. AJR Am J Roentgenol 1987; 149: 473-5.
25. White PM, Howard GC, Best JJ, Wright AR. The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours. Clin Radiol 1997; 52: 124-9.
26. White PM, Adamson DJ, Howard GC, Wright AR. Imaging of the thorax in the management of germ cell testicular tumours. Clin Radiol 1999; 54: 207-11.
27. Bassalleck B, Berdoz A, Bradtke C, Broders R, Bunker B, Dennert H et al. Measurement of spin-transfer observables in pp ! 33 at 1.637 GeV/c. Phys Rev Lett 2002; 89: 212-302.
28. Meyer CA, Conces DJ. Imaging of intrathoracic metastases of nonseminomatous germ cell tumors. Chest Surg Clin N Am 2002; 12: 717-38.
29. Kozuka T, Johkoh T, Hamada S, Naito H, Tomiyama N, Koyama M et al. Detection of pulmonary metastases with multidetector row CT scans of 5-mm nominal section thickness: autopsy lung study. Radiology 2003; 226: 231-4.
30. Husband JE, Koh DM. Testicular germ cell tumours. In: Imaging in Oncology, 2nd edn. Husband JE, Reznek RH, eds. London: Taylor and Francis, 2004: 401-27.
31. Freedman LS, Parkinson MC, Jones WG, Oliver RT, Peckham MJ, Read G et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2: 294-8.
32. Thompson PI, Nixon J, Harvey VJ. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance. J Clin Oncol 1988; 6: 1597-603.
33. Nicolai N, Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 1995; 154: 1045-9.
34. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular TumorsWorking Party. J Clin Oncol 1992; 10: 1762-8.
35. Peckham MJ, Barrett A, Husband JE, Hendry WF. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet 1982; 2: 678-80.
36. Stomper PC, Fung CY, Socinski MA, Jochelson MS, Garnick MB, Richie JP. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria. AJR Am J Roentgenol 1987; 149: 1187-90.
37. Lien HH, Stenwig AE, Ous S, Fossa SD. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor. Acta Radiol Diagn (Stockh) 1986; 27: 199-203.
38. Thomas JL, Bernardino ME, Bracken RB. Staging of testicular carcinoma: comparison of CT and lymphangiography. AJR Am J Roentgenol 1981; 137: 991-6.
39. Rowland RG,Weisman D,Williams SD, Einhorn LH, Klatte EC, Donohue JP. Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors. J Urol 1982; 127: 718-20.
40. Richie JP, Garnick MB, Finberg H. Computerized tomography: how accurate for abdominal staging of testis tumors? J Urol 1982; 127: 715-7.
41. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991; 180: 319-22.
42. Magnusson A. Size of normal retroperitoneal lymph nodes. Acta Radiol Diagn (Stockh) 1983; 24: 315-8.
43. Forsberg L, Dale L, Hoiem L, Magnusson A, Mikulowski P, Olsson AM et al. Computed tomography in early stages of testicular carcinoma. Size of normal retroperitoneal lymph nodes and lymph nodes in patients with metastases in stage II A. A SWENOTECA study: Swedish-Norwegian Testicular Cancer Project. Acta Radiol Diagn (Stockh) 1986; 27: 569-74.
44. Bokemeyer C, Nowak P, Haupt A, Metzner B, Kohne H, Hartmann JT et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997; 15: 1449-54.
45. Fossa SD, Bokemeyer C, Gerl A, Culine S, Jones WG, Mead GM et al. Treatment outcome of patients with brain metastases from malignant germ cell tumors. Cancer 1999; 85: 988-97.
46. [Conference proceedings] Sohaib SA, Huddart R, Dearnaley DP, Horwich A, Husband J. Sensitivity of MRI in the diagnosis of retroperitoneal disease in testicular germ cell tumour. Am J Roentegenol 2005; 184 (Suppl 4): 63.
47. Ellis JH, Bies JR, Kopecky KK, Klatte EC, Rowland RG, Donohue JP. Comparison of NMR and CT imaging in the evaluation of metastatic retroperitoneal lymphadenopathy from testicular carcinoma. J Comput Assist Tomogr 1984; 8: 709-19.
48. Lawton AJ, Mead GM. Staging and prognostic factors in testicular cancer. Semin Surg Oncol 1999; 17: 223-9.
49. Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR et al. Diagnostic performance of nanoparticleenhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005; 23: 2813-21.
50. Harisinghani MG, Saksena M, Ross RW, Tabatabaei S, Dahl D, McDougal S et al. A pilot study of lymphotrophic nanoparticleenhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology 2005; 66: 1066-71.
51. Harisinghani MG, Saini S, Weissleder R, Hahn PF, Yantiss RK, Tempany C et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. AJR Am J Roentgenol 1999; 172: 1347-51.
52. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-9.
53. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003; 228: 777-88.
54. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 2003; 28: 155-63.
55. Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings: initial observations. Radiology 2004; 231: 91-9.
56. Cremerius U, Effert PJ, Adam G, Sabri O, Zimmy M, Wagenknecht G et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 1998; 39: 815-22.
57. Ravi R, Ong J, Oliver RT, Badenoch DF, Fowler CG, Hendry WF. The management of residual masses after chemotherapy in metastatic seminoma. BJU Int 1999; 83: 649-53.
58. Albers P, Bender H, Yilmaz H, Schoeneich G, Biersack HJ, Mueller SC. Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 1999; 53: 808-11.
59. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 2000; 27: 590-4.
60. Cremerius U, Wildberger JE, Borchers H, Zimny M, Jakse G, Gunther RW et al. Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients. Urology 1999; 54: 900-4.
61. Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001; 42: 1S-93S.
62. Karapetis CS, Strickland AH, Yip D, Steer C, Harper PG. Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow up. Intern Med J 2003; 33: 427-35.
63. Hain SF, Maisey MN. Positron emission tomography for urological tumours. BJU Int 2003; 92: 159-64.
64. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Harper PG, Huddart RA. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 2000; 83: 863-9.
65. Huddart R, O'Doherty M, Padhani AR, Rustin GJ, Mead GM, Selby P et al. A prospective study of 18FDG PET in the prediction of relapse in patients with high risk clinical stage 1 non-seminomatous germ cell cancer (MRCstudy TE22). European Journal of Cancer 2005; 3 (Suppl 2): 227 [Abstract].
66. Jones RH, Vasey PA. Part I: testicular cancer: management of early disease. Lancet Oncol 2003; 4: 730-7.
67. Freedman LS, Parkinson MC, Jones WG, Oliver RT, Peckham MJ, Read G et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 1987; 2: 294-8.
68. Read G, Stenning SP, Cullen MH, Parkinson MC, Horwich A, Kaye SB et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular TumorsWorking Party. J Clin Oncol 1992; 10: 1762-8.
69. Nathan PD, Rustin GR. The role of CT scanning in the surveillance of testicular tumours. Clin Oncol (R Coll Radiol) 2003; 15: 121-2.
70. Harvey ML, Geldart TR, Duell R, Mead GM, Tung K. Routine computerised tomographic scans of the thorax in surveillance of stage I testicular non-seminomatous germ-cell cancer: a necessary risk? Ann Oncol 2002; 13: 237-42.
71. Crawford SM, Rustin GJ, Begent RH, Newlands ES, Bagshawe KD. Safety of surveillance in the management of stage I anaplastic germ cell tumours of the testis. Br J Urol 1988; 61: 250-3.
72. Hellerstedt BA, Pienta KJ. Germ cell tumors: review of selected studies from 2002. Curr Opin Oncol 2003; 15: 234-8.
73. Gietema JA, Meinardi MT, Sleijfer DT, Hoekstra HJ, van der Graaf WT. Routine chest X-rays have no additional value in the detection of relapse during routine follow-up of patients treated with chemotherapy for disseminated nonseminomatous testicular cancer. Ann Oncol 2002; 13: 1616-20.
74. Lentini JF, Love MB, Ritchie WG, Sedlacek TV. Computed tomography in retroconversion of hepatic metastases from immature ovarian teratoma. J Comput Assist Tomogr 1986; 10: 1060-2.
75. Moskovic E, Jobling T, Fisher C, Wiltshaw E, Parsons C. Retroconversion of immature teratoma of the ovary: CT appearances. Clin Radiol 1991; 43: 402-8.
76. Connor S, Guest P. Conversion of multiple solid testicular teratoma metastases to fatty and cystic liver masses following chemotherapy: CT evidence of maturation'. Br J Radiol 1999; 72: 1114-16.
77. Williams MP, Naik G, Heron CW, Husband JE. Computed tomography of the abdomen in advanced seminoma: response to treatment. Clin Radiol 1987; 38: 629-33.
78. Charig MJ, Williams MP. Pulmonary lacunae: sequelae of metastases following chemotherapy. Clin Radiol 1990; 42: 93-6.
79. Husband JE, Barrett A, Peckham MJ. The role of computed tomography in the assessment of tumour volume in patients with malignant testicular teratoma. Br J Radiol 1981; 15: 50-3.
80. Hendry WF, A'Hern RP, Hetherington JW, Peckham MJ, Dearnaley DP, Horwich A. Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. Br J Urol 1993; 71: 208-13.
81. Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology 1999; 211: 249-56.
82. De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F et al. 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 2004; 22: 1034-9.
83. Becherer A, De Santis M, Karanikas G, Szabo M, Bokemeyer C, Dohmen BM et al. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals. Eur J Radiol 2005; 54: 284-8.
84. Stephens AW, Gonin R, Hutchins GD, Einhorn LH. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996; 14: 1637-41.
85. Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen BM, Pfannenberg A, Claussen CD et al. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET. Br J Cancer 2002; 86: 506-11.